Dataset | Score | p-value 1 | p-value 2 | p-value 3 |
---|---|---|---|---|
wolf-screen-ratio-mammosphere-adherent | 0.941 | 9.03e-16 | 2.14e-03 | 3.61e-02 |
Gene Symbol | Entrez Gene ID | Frequency | wolf-screen-ratio-mammosphere-adherent gene score | Best subnetwork score | Degree | wolf adherent-list Hits GI | wolf mammosphere no adherent-list Hits GI |
---|---|---|---|---|---|---|---|
RBX1 | 9978 | 97 | 1.185 | 1.151 | 139 | Yes | - |
PHB2 | 11331 | 9 | 0.829 | 1.076 | 140 | Yes | - |
HNRNPC | 3183 | 20 | 1.812 | 1.026 | 119 | Yes | - |
RPL6 | 6128 | 11 | 0.844 | 1.113 | 164 | Yes | - |
PSMB7 | 5695 | 48 | 0.982 | 1.052 | 57 | Yes | - |
SMARCA4 | 6597 | 1 | 0.416 | 0.941 | 253 | - | - |
PSMA1 | 5682 | 61 | 0.996 | 1.052 | 123 | Yes | - |
ATP6V1B2 | 526 | 44 | 0.881 | 1.076 | 278 | - | - |
RPSA | 3921 | 156 | 1.327 | 1.151 | 152 | Yes | - |
RPS3A | 6189 | 11 | 0.835 | 1.069 | 166 | Yes | - |
RPA2 | 6118 | 98 | 1.250 | 1.151 | 69 | Yes | - |
CAD | 790 | 17 | 0.807 | 1.007 | 333 | - | - |
CDC16 | 8881 | 25 | 0.950 | 1.020 | 80 | Yes | - |
[ GTF2A1 ] | 2957 | 1 | 0.251 | 0.941 | 52 | - | - |
EEF2 | 1938 | 27 | 0.890 | 1.043 | 301 | Yes | - |
PSMD13 | 5719 | 16 | 0.848 | 1.029 | 104 | Yes | - |
PSMD3 | 5709 | 57 | 0.986 | 1.106 | 146 | Yes | - |
CLTC | 1213 | 35 | 0.884 | 1.138 | 247 | Yes | - |
PSMB2 | 5690 | 18 | 0.877 | 1.026 | 117 | Yes | - |
PSMD11 | 5717 | 121 | 1.095 | 1.106 | 183 | Yes | - |
ACTB | 60 | 167 | 1.153 | 1.151 | 587 | Yes | - |
PSMD6 | 9861 | 11 | 0.848 | 1.009 | 131 | Yes | - |
FBL | 2091 | 7 | 0.839 | 1.151 | 65 | Yes | - |
HSPD1 | 3329 | 35 | 0.913 | 1.035 | 286 | Yes | - |
PSMC1 | 5700 | 14 | 0.840 | 1.018 | 137 | Yes | - |
Gene Symbol 1 | Entrez Gene ID 1 | Gene Symbol 2 | Entrez Gene ID 2 | Type | Direction | Origin databases / Sources |
---|---|---|---|---|---|---|
PSMD3 | 5709 | PSMD13 | 5719 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, MINT_Yeast, YeastHigh, BioGrid, BioGrid_Yeast, IntAct_Yeast, Krogan_Core |
ACTB | 60 | FBL | 2091 | pp | -- | int.I2D: MINT |
PSMD3 | 5709 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
PSMA1 | 5682 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMC1 | 5700 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, MINT_Yeast, BioGrid, IntAct_Yeast, Krogan_Core, YeastHigh |
CAD | 790 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
CAD | 790 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct |
PSMD11 | 5717 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, BioGrid, INTEROLOG |
PSMA1 | 5682 | PSMD6 | 9861 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, YeastMedium |
ACTB | 60 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
HSPD1 | 3329 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | ATP6V1B2 | 526 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | RPSA | 3921 | pp | -- | int.I2D: IntAct_Yeast |
PSMD11 | 5717 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Yeast, Krogan_Core, MINT_Yeast, Tarassov_PCA, YeastHigh, BioGrid, INTEROLOG |
RPL6 | 6128 | RPS3A | 6189 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA1 | 5682 | PSMC1 | 5700 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct_Fly, YeastMedium, IntAct |
CAD | 790 | CDC16 | 8881 | pp | -- | int.I2D: IntAct_Yeast |
RPSA | 3921 | PSMD11 | 5717 | pp | -- | int.I2D: IntAct_Yeast |
EEF2 | 1938 | PSMD13 | 5719 | pp | -- | int.I2D: YeastLow |
PSMC1 | 5700 | PHB2 | 11331 | pp | -- | int.I2D: BioGrid_Yeast |
PSMA1 | 5682 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
ACTB | 60 | RPSA | 3921 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct_Yeast, IntAct |
PSMA1 | 5682 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, IntAct, IntAct_Mouse, IntAct_Yeast, YeastLow, Krogan_Core, MINT_Yeast |
ACTB | 60 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | RBX1 | 9978 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMD13 | 5719 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMD3 | 5709 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid_Worm, BioGrid_Yeast, BIND_Worm, CE_DATA, IntAct, IntAct_Yeast, MINT_Worm, MINT_Yeast, YeastHigh, BioGrid, BIND_Yeast, IntAct_Worm, INTEROLOG, Krogan_Core, MIPS |
PSMB7 | 5695 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
PSMB2 | 5690 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
ACTB | 60 | GTF2A1 | 2957 | pp | -- | int.I2D: BioGrid_Yeast |
ATP6V1B2 | 526 | CDC16 | 8881 | pp | -- | int.I2D: IntAct_Yeast |
PSMB7 | 5695 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC1 | 5700 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast, Krogan_Core, MINT_Yeast, YeastHigh, INTEROLOG |
ACTB | 60 | PSMB2 | 5690 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
PSMD13 | 5719 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: BioGrid, BioGrid_Yeast, IntAct, IntAct_Yeast, MINT_Yeast, YeastHigh, Krogan_Core |
ACTB | 60 | PSMB7 | 5695 | pp | -- | int.I2D: BioGrid_Yeast |
PSMC1 | 5700 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: BioGrid_Yeast, IntAct, MINT_Yeast, YeastHigh, BioGrid, IntAct_Yeast, Krogan_Core |
GTF2A1 | 2957 | SMARCA4 | 6597 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | RPS3A | 6189 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMB2 | 5690 | PSMB7 | 5695 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastLow, IntAct |
ATP6V1B2 | 526 | CLTC | 1213 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | CDC16 | 8881 | pp | -- | int.I2D: YeastLow |
RPS3A | 6189 | PSMD6 | 9861 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
PSMB7 | 5695 | PSMC1 | 5700 | pp | -- | int.I2D: BioGrid_Yeast |
PSMB2 | 5690 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast, YeastLow |
CAD | 790 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
RPSA | 3921 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | CAD | 790 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | PSMA1 | 5682 | pp | -- | int.I2D: BioGrid_Yeast |
EEF2 | 1938 | HSPD1 | 3329 | pp | -- | int.I2D: YeastLow, YeastMedium |
HSPD1 | 3329 | RPSA | 3921 | pp | -- | int.I2D: BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | RPA2 | 6118 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct |
ACTB | 60 | EEF2 | 1938 | pp | -- | int.I2D: YeastLow, IntAct_Yeast |
PSMB2 | 5690 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast, YeastMedium |
ACTB | 60 | RPL6 | 6128 | pp | -- | int.I2D: BioGrid_Yeast |
EEF2 | 1938 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
ACTB | 60 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
PSMA1 | 5682 | PSMB2 | 5690 | pp | -- | int.Intact: MI:0915(physical association), MI:0914(association); int.I2D: HPRD, IntAct, IntAct_Mouse, IntAct_Yeast, INTEROLOG, BioGrid_Yeast, Krogan_Core, MINT_Yeast, YeastHigh; int.HPRD: yeast 2-hybrid |
PSMA1 | 5682 | PSMD13 | 5719 | pp | -- | int.Proteinpedia: Mass spectrometry; int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastMedium, BioGrid, BioGrid_Yeast, IntAct_Yeast |
ACTB | 60 | SMARCA4 | 6597 | pp | -- | int.Intact: MI:0914(association); int.I2D: BioGrid, IntAct, BCI, HPRD; int.HPRD: in vitro, in vivo |
ACTB | 60 | PSMD6 | 9861 | pp | -- | int.I2D: BioGrid_Yeast |
ACTB | 60 | PSMD11 | 5717 | pp | -- | int.I2D: BioGrid_Yeast |
HNRNPC | 3183 | SMARCA4 | 6597 | pp | -- | int.I2D: BioGrid |
RPS3A | 6189 | PHB2 | 11331 | pp | -- | int.I2D: IntAct_Yeast |
PSMC1 | 5700 | PSMD3 | 5709 | pp | -- | int.I2D: BioGrid_Yeast, MINT_Yeast, YeastHigh, Krogan_Core |
EEF2 | 1938 | PSMD3 | 5709 | pp | -- | int.I2D: Krogan_NonCore |
ACTB | 60 | HSPD1 | 3329 | pp | -- | int.Intact: MI:0915(physical association); int.I2D: IntAct, YeastLow |
ACTB | 60 | PSMD13 | 5719 | pp | -- | int.I2D: BioGrid_Yeast |
Accession number | Name | Hypergeometric test | Corrected p-value | Enrichment ratio | Occurrence in subnetwork | Occurrences in all snw genes | Occurrences in all int/reg genes |
---|---|---|---|---|---|---|---|
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.32e-16 | 1.20e-11 | 6.320 | 9 | 22 | 65 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 1.68e-15 | 2.43e-11 | 6.213 | 9 | 22 | 70 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2.85e-15 | 4.11e-11 | 6.133 | 9 | 22 | 74 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 5.28e-15 | 7.62e-11 | 6.038 | 9 | 23 | 79 |
GO:0006521 | regulation of cellular amino acid metabolic process | 1.20e-14 | 1.73e-10 | 6.528 | 8 | 17 | 50 |
GO:0016032 | viral process | 2.36e-14 | 3.40e-10 | 3.919 | 14 | 55 | 534 |
GO:0016071 | mRNA metabolic process | 3.48e-14 | 5.01e-10 | 4.831 | 11 | 31 | 223 |
GO:0000502 | proteasome complex | 4.24e-14 | 6.12e-10 | 6.314 | 8 | 17 | 58 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 9.74e-14 | 1.40e-09 | 6.172 | 8 | 19 | 64 |
GO:0016070 | RNA metabolic process | 1.07e-13 | 1.55e-09 | 4.683 | 11 | 32 | 247 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 2.61e-13 | 3.77e-09 | 6.002 | 8 | 20 | 72 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 3.67e-13 | 5.29e-09 | 5.943 | 8 | 20 | 75 |
GO:0010467 | gene expression | 5.18e-13 | 7.48e-09 | 3.594 | 14 | 59 | 669 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.86e-12 | 2.69e-08 | 5.123 | 9 | 32 | 149 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.99e-12 | 2.87e-08 | 5.649 | 8 | 21 | 92 |
GO:0005829 | cytosol | 1.19e-11 | 1.71e-07 | 2.209 | 20 | 132 | 2496 |
GO:0000209 | protein polyubiquitination | 1.32e-11 | 1.91e-07 | 5.314 | 8 | 20 | 116 |
GO:0022624 | proteasome accessory complex | 6.24e-11 | 9.00e-07 | 7.407 | 5 | 8 | 17 |
GO:0042981 | regulation of apoptotic process | 1.06e-10 | 1.52e-06 | 4.943 | 8 | 24 | 150 |
GO:0034641 | cellular nitrogen compound metabolic process | 3.02e-10 | 4.35e-06 | 4.754 | 8 | 20 | 171 |
GO:0005654 | nucleoplasm | 3.35e-10 | 4.84e-06 | 2.900 | 14 | 76 | 1082 |
GO:0000278 | mitotic cell cycle | 4.35e-10 | 6.27e-06 | 3.883 | 10 | 48 | 391 |
GO:0043066 | negative regulation of apoptotic process | 9.55e-10 | 1.38e-05 | 3.766 | 10 | 31 | 424 |
GO:0070062 | extracellular vesicular exosome | 1.33e-09 | 1.91e-05 | 2.113 | 18 | 104 | 2400 |
GO:0005838 | proteasome regulatory particle | 3.44e-09 | 4.96e-05 | 7.587 | 4 | 7 | 12 |
GO:0016020 | membrane | 9.79e-09 | 1.41e-04 | 2.364 | 15 | 90 | 1681 |
GO:0043234 | protein complex | 4.89e-07 | 7.05e-03 | 3.775 | 7 | 18 | 295 |
GO:0006915 | apoptotic process | 2.77e-06 | 3.99e-02 | 3.056 | 8 | 33 | 555 |
GO:0005839 | proteasome core complex | 3.69e-06 | 5.32e-02 | 6.587 | 3 | 8 | 18 |
GO:0004298 | threonine-type endopeptidase activity | 4.38e-06 | 6.31e-02 | 6.509 | 3 | 8 | 19 |
GO:0043044 | ATP-dependent chromatin remodeling | 7.96e-06 | 1.15e-01 | 6.234 | 3 | 4 | 23 |
GO:0031492 | nucleosomal DNA binding | 1.31e-05 | 1.89e-01 | 6.002 | 3 | 4 | 27 |
GO:0006414 | translational elongation | 1.85e-05 | 2.66e-01 | 4.633 | 4 | 13 | 93 |
GO:0005730 | nucleolus | 3.90e-05 | 5.62e-01 | 1.951 | 11 | 69 | 1641 |
GO:0005634 | nucleus | 3.93e-05 | 5.67e-01 | 1.188 | 18 | 136 | 4559 |
GO:0044822 | poly(A) RNA binding | 4.08e-05 | 5.88e-01 | 2.298 | 9 | 49 | 1056 |
GO:0030957 | Tat protein binding | 4.31e-05 | 6.21e-01 | 7.587 | 2 | 3 | 6 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 1.02e-04 | 1.00e+00 | 5.029 | 3 | 5 | 53 |
GO:0044281 | small molecule metabolic process | 1.19e-04 | 1.00e+00 | 2.100 | 9 | 58 | 1211 |
GO:0003723 | RNA binding | 2.62e-04 | 1.00e+00 | 3.076 | 5 | 20 | 342 |
GO:0019083 | viral transcription | 3.59e-04 | 1.00e+00 | 4.417 | 3 | 10 | 81 |
GO:0017025 | TBP-class protein binding | 3.86e-04 | 1.00e+00 | 6.085 | 2 | 3 | 17 |
GO:0006415 | translational termination | 4.43e-04 | 1.00e+00 | 4.314 | 3 | 10 | 87 |
GO:0001649 | osteoblast differentiation | 5.22e-04 | 1.00e+00 | 4.234 | 3 | 6 | 92 |
GO:0005515 | protein binding | 5.37e-04 | 1.00e+00 | 0.864 | 19 | 184 | 6024 |
GO:0006412 | translation | 6.12e-04 | 1.00e+00 | 3.327 | 4 | 20 | 230 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 6.52e-04 | 1.00e+00 | 5.713 | 2 | 4 | 22 |
GO:0005844 | polysome | 7.14e-04 | 1.00e+00 | 5.649 | 2 | 4 | 23 |
GO:0006614 | SRP-dependent cotranslational protein targeting to membrane | 7.46e-04 | 1.00e+00 | 4.057 | 3 | 10 | 104 |
GO:0030529 | ribonucleoprotein complex | 9.26e-04 | 1.00e+00 | 3.950 | 3 | 8 | 112 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 9.74e-04 | 1.00e+00 | 3.924 | 3 | 11 | 114 |
GO:0019058 | viral life cycle | 9.99e-04 | 1.00e+00 | 3.912 | 3 | 13 | 115 |
GO:0044267 | cellular protein metabolic process | 1.16e-03 | 1.00e+00 | 2.605 | 5 | 29 | 474 |
GO:0033572 | transferrin transport | 1.22e-03 | 1.00e+00 | 5.265 | 2 | 5 | 30 |
GO:0000790 | nuclear chromatin | 1.39e-03 | 1.00e+00 | 3.746 | 3 | 9 | 129 |
GO:0006413 | translational initiation | 1.46e-03 | 1.00e+00 | 3.724 | 3 | 17 | 131 |
GO:0006200 | ATP catabolic process | 1.49e-03 | 1.00e+00 | 2.982 | 4 | 15 | 292 |
GO:0003735 | structural constituent of ribosome | 1.65e-03 | 1.00e+00 | 3.659 | 3 | 10 | 137 |
GO:0002842 | positive regulation of T cell mediated immune response to tumor cell | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0048291 | isotype switching to IgG isotypes | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:1990259 | histone-glutamine methyltransferase activity | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:1990258 | histone glutamine methylation | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0004151 | dihydroorotase activity | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0016074 | snoRNA metabolic process | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0002368 | B cell cytokine production | 1.73e-03 | 1.00e+00 | 9.172 | 1 | 1 | 1 |
GO:0016887 | ATPase activity | 1.76e-03 | 1.00e+00 | 3.628 | 3 | 7 | 140 |
GO:0022627 | cytosolic small ribosomal subunit | 2.06e-03 | 1.00e+00 | 4.887 | 2 | 4 | 39 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 2.81e-03 | 1.00e+00 | 3.391 | 3 | 7 | 165 |
GO:0005925 | focal adhesion | 3.38e-03 | 1.00e+00 | 2.657 | 4 | 19 | 366 |
GO:0035887 | aortic smooth muscle cell differentiation | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0006407 | rRNA export from nucleus | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0000461 | endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0005055 | laminin receptor activity | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0007127 | meiosis I | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0007070 | negative regulation of transcription from RNA polymerase II promoter during mitosis | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 3.46e-03 | 1.00e+00 | 8.172 | 1 | 1 | 2 |
GO:0003725 | double-stranded RNA binding | 3.63e-03 | 1.00e+00 | 4.472 | 2 | 5 | 52 |
GO:0002039 | p53 binding | 4.05e-03 | 1.00e+00 | 4.391 | 2 | 7 | 55 |
GO:0010424 | DNA methylation on cytosine within a CG sequence | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 2 | 3 |
GO:0006458 | 'de novo' protein folding | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0001832 | blastocyst growth | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0007403 | glial cell fate determination | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0030135 | coated vesicle | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0005726 | perichromatin fibrils | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 5.19e-03 | 1.00e+00 | 7.587 | 1 | 2 | 3 |
GO:0003697 | single-stranded DNA binding | 6.13e-03 | 1.00e+00 | 4.085 | 2 | 5 | 68 |
GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0030686 | 90S preribosome | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0032051 | clathrin light chain binding | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0019788 | NEDD8 ligase activity | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0001652 | granular component | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0031428 | box C/D snoRNP complex | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0060318 | definitive erythrocyte differentiation | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0006543 | glutamine catabolic process | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0001835 | blastocyst hatching | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 2 | 4 |
GO:0031467 | Cul7-RING ubiquitin ligase complex | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 6.92e-03 | 1.00e+00 | 7.172 | 1 | 1 | 4 |
GO:0001889 | liver development | 7.79e-03 | 1.00e+00 | 3.905 | 2 | 4 | 77 |
GO:0003407 | neural retina development | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0051414 | response to cortisol | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 3 | 5 |
GO:0005672 | transcription factor TFIIA complex | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:2000001 | regulation of DNA damage checkpoint | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0048562 | embryonic organ morphogenesis | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0031461 | cullin-RING ubiquitin ligase complex | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0043248 | proteasome assembly | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0046696 | lipopolysaccharide receptor complex | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0030891 | VCB complex | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 2 | 5 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0000730 | DNA recombinase assembly | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0048730 | epidermis morphogenesis | 8.64e-03 | 1.00e+00 | 6.850 | 1 | 1 | 5 |
GO:0047485 | protein N-terminus binding | 9.64e-03 | 1.00e+00 | 3.746 | 2 | 5 | 86 |
GO:0002181 | cytoplasmic translation | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0003688 | DNA replication origin binding | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 6 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 3 | 6 |
GO:0060744 | mammary gland branching involved in thelarche | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0006346 | methylation-dependent chromatin silencing | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0030118 | clathrin coat | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 2 | 6 |
GO:0031466 | Cul5-RING ubiquitin ligase complex | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis | 1.04e-02 | 1.00e+00 | 6.587 | 1 | 1 | 6 |
GO:0016363 | nuclear matrix | 1.07e-02 | 1.00e+00 | 3.664 | 2 | 12 | 91 |
GO:0042470 | melanosome | 1.07e-02 | 1.00e+00 | 3.664 | 2 | 9 | 91 |
GO:0000028 | ribosomal small subunit assembly | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 1 | 7 |
GO:0031462 | Cul2-RING ubiquitin ligase complex | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 7 |
GO:0033180 | proton-transporting V-type ATPase, V1 domain | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 7 |
GO:0030132 | clathrin coat of coated pit | 1.21e-02 | 1.00e+00 | 6.365 | 1 | 2 | 7 |
GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 8 |
GO:0070688 | MLL5-L complex | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 8 |
GO:0070182 | DNA polymerase binding | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 8 |
GO:0045116 | protein neddylation | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 2 | 8 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 4 | 8 |
GO:0051604 | protein maturation | 1.38e-02 | 1.00e+00 | 6.172 | 1 | 1 | 8 |
GO:0014075 | response to amine | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 9 |
GO:0008494 | translation activator activity | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 9 |
GO:0006228 | UTP biosynthetic process | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 1 | 9 |
GO:0031000 | response to caffeine | 1.55e-02 | 1.00e+00 | 6.002 | 1 | 2 | 9 |
GO:0005819 | spindle | 1.60e-02 | 1.00e+00 | 3.365 | 2 | 7 | 112 |
GO:0019901 | protein kinase binding | 1.69e-02 | 1.00e+00 | 2.449 | 3 | 21 | 317 |
GO:0010569 | regulation of double-strand break repair via homologous recombination | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 1 | 10 |
GO:0043032 | positive regulation of macrophage activation | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 1 | 10 |
GO:0070307 | lens fiber cell development | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 2 | 10 |
GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway | 1.72e-02 | 1.00e+00 | 5.850 | 1 | 1 | 10 |
GO:0032727 | positive regulation of interferon-alpha production | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 1 | 11 |
GO:0031571 | mitotic G1 DNA damage checkpoint | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 4 | 11 |
GO:0045120 | pronucleus | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 11 |
GO:0043923 | positive regulation by host of viral transcription | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 2 | 11 |
GO:0071564 | npBAF complex | 1.89e-02 | 1.00e+00 | 5.713 | 1 | 3 | 11 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 2 | 12 |
GO:0071565 | nBAF complex | 2.06e-02 | 1.00e+00 | 5.587 | 1 | 3 | 12 |
GO:0005524 | ATP binding | 2.09e-02 | 1.00e+00 | 1.415 | 6 | 60 | 1298 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 13 |
GO:0005662 | DNA replication factor A complex | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 3 | 13 |
GO:0001530 | lipopolysaccharide binding | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 3 | 13 |
GO:0008266 | poly(U) RNA binding | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 13 |
GO:0051131 | chaperone-mediated protein complex assembly | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 13 |
GO:0035267 | NuA4 histone acetyltransferase complex | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 4 | 14 |
GO:0060347 | heart trabecula formation | 2.40e-02 | 1.00e+00 | 5.365 | 1 | 1 | 14 |
GO:0030902 | hindbrain development | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 1 | 15 |
GO:0042026 | protein refolding | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 2 | 15 |
GO:0046034 | ATP metabolic process | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 1 | 15 |
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 3 | 15 |
GO:0016514 | SWI/SNF complex | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 3 | 15 |
GO:0060749 | mammary gland alveolus development | 2.57e-02 | 1.00e+00 | 5.265 | 1 | 2 | 15 |
GO:0061024 | membrane organization | 2.59e-02 | 1.00e+00 | 2.992 | 2 | 7 | 145 |
GO:0042176 | regulation of protein catabolic process | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 3 | 16 |
GO:0050998 | nitric-oxide synthase binding | 2.74e-02 | 1.00e+00 | 5.172 | 1 | 1 | 16 |
GO:0010243 | response to organonitrogen compound | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 3 | 17 |
GO:0006337 | nucleosome disassembly | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 3 | 17 |
GO:0006541 | glutamine metabolic process | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 1 | 17 |
GO:0003746 | translation elongation factor activity | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 3 | 17 |
GO:0050870 | positive regulation of T cell activation | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 1 | 17 |
GO:0070577 | lysine-acetylated histone binding | 2.91e-02 | 1.00e+00 | 5.085 | 1 | 1 | 17 |
GO:0035861 | site of double-strand break | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 18 |
GO:0007088 | regulation of mitosis | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 18 |
GO:0017144 | drug metabolic process | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 1 | 18 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 3.24e-02 | 1.00e+00 | 4.924 | 1 | 3 | 19 |
GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process | 3.24e-02 | 1.00e+00 | 4.924 | 1 | 1 | 19 |
GO:0048863 | stem cell differentiation | 3.24e-02 | 1.00e+00 | 4.924 | 1 | 1 | 19 |
GO:0032733 | positive regulation of interleukin-10 production | 3.24e-02 | 1.00e+00 | 4.924 | 1 | 1 | 19 |
GO:0005719 | nuclear euchromatin | 3.24e-02 | 1.00e+00 | 4.924 | 1 | 2 | 19 |
GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 2 | 20 |
GO:0005680 | anaphase-promoting complex | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 4 | 20 |
GO:0006298 | mismatch repair | 3.41e-02 | 1.00e+00 | 4.850 | 1 | 3 | 20 |
GO:0042100 | B cell proliferation | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 21 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 4 | 21 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 1 | 21 |
GO:0032201 | telomere maintenance via semi-conservative replication | 3.58e-02 | 1.00e+00 | 4.780 | 1 | 5 | 21 |
GO:0000792 | heterochromatin | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 2 | 22 |
GO:0006206 | pyrimidine nucleobase metabolic process | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 2 | 22 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 3 | 22 |
GO:0033574 | response to testosterone | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 2 | 22 |
GO:0030863 | cortical cytoskeleton | 3.75e-02 | 1.00e+00 | 4.713 | 1 | 1 | 22 |
GO:0031625 | ubiquitin protein ligase binding | 3.77e-02 | 1.00e+00 | 2.696 | 2 | 14 | 178 |
GO:0031463 | Cul3-RING ubiquitin ligase complex | 3.91e-02 | 1.00e+00 | 4.649 | 1 | 3 | 23 |
GO:0043236 | laminin binding | 3.91e-02 | 1.00e+00 | 4.649 | 1 | 1 | 23 |
GO:0006513 | protein monoubiquitination | 3.91e-02 | 1.00e+00 | 4.649 | 1 | 1 | 23 |
GO:0001105 | RNA polymerase II transcription coactivator activity | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 1 | 24 |
GO:0043388 | positive regulation of DNA binding | 4.08e-02 | 1.00e+00 | 4.587 | 1 | 1 | 24 |
GO:0000722 | telomere maintenance via recombination | 4.25e-02 | 1.00e+00 | 4.528 | 1 | 5 | 25 |
GO:0042113 | B cell activation | 4.25e-02 | 1.00e+00 | 4.528 | 1 | 2 | 25 |
GO:0032735 | positive regulation of interleukin-12 production | 4.25e-02 | 1.00e+00 | 4.528 | 1 | 1 | 25 |
GO:0070979 | protein K11-linked ubiquitination | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 6 | 26 |
GO:0015991 | ATP hydrolysis coupled proton transport | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 4 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 3 | 26 |
GO:0003730 | mRNA 3'-UTR binding | 4.41e-02 | 1.00e+00 | 4.472 | 1 | 2 | 26 |
GO:0030177 | positive regulation of Wnt signaling pathway | 4.58e-02 | 1.00e+00 | 4.417 | 1 | 3 | 27 |
GO:0030331 | estrogen receptor binding | 4.58e-02 | 1.00e+00 | 4.417 | 1 | 2 | 27 |
GO:0043022 | ribosome binding | 4.58e-02 | 1.00e+00 | 4.417 | 1 | 3 | 27 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 4.75e-02 | 1.00e+00 | 4.365 | 1 | 1 | 28 |
GO:0019005 | SCF ubiquitin ligase complex | 4.91e-02 | 1.00e+00 | 4.314 | 1 | 1 | 29 |
GO:0015992 | proton transport | 4.91e-02 | 1.00e+00 | 4.314 | 1 | 3 | 29 |
GO:0006271 | DNA strand elongation involved in DNA replication | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 7 | 30 |
GO:0035116 | embryonic hindlimb morphogenesis | 5.08e-02 | 1.00e+00 | 4.265 | 1 | 1 | 30 |
GO:0031623 | receptor internalization | 5.24e-02 | 1.00e+00 | 4.218 | 1 | 2 | 31 |
GO:0007094 | mitotic spindle assembly checkpoint | 5.24e-02 | 1.00e+00 | 4.218 | 1 | 4 | 31 |
GO:0051701 | interaction with host | 5.41e-02 | 1.00e+00 | 4.172 | 1 | 4 | 32 |
GO:0032588 | trans-Golgi network membrane | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 2 | 34 |
GO:0008094 | DNA-dependent ATPase activity | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 2 | 34 |
GO:0008033 | tRNA processing | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 1 | 34 |
GO:0001895 | retina homeostasis | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 1 | 34 |
GO:0005876 | spindle microtubule | 5.73e-02 | 1.00e+00 | 4.085 | 1 | 2 | 34 |
GO:0007067 | mitotic nuclear division | 5.84e-02 | 1.00e+00 | 2.346 | 2 | 14 | 227 |
GO:0034332 | adherens junction organization | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 1 | 36 |
GO:0090382 | phagosome maturation | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 5 | 36 |
GO:0032755 | positive regulation of interleukin-6 production | 6.06e-02 | 1.00e+00 | 4.002 | 1 | 2 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 6.22e-02 | 1.00e+00 | 3.963 | 1 | 4 | 37 |
GO:0006284 | base-excision repair | 6.22e-02 | 1.00e+00 | 3.963 | 1 | 3 | 37 |
GO:0018107 | peptidyl-threonine phosphorylation | 6.22e-02 | 1.00e+00 | 3.963 | 1 | 4 | 37 |
GO:0003713 | transcription coactivator activity | 6.30e-02 | 1.00e+00 | 2.283 | 2 | 10 | 237 |
GO:0005902 | microvillus | 6.39e-02 | 1.00e+00 | 3.924 | 1 | 2 | 38 |
GO:0070527 | platelet aggregation | 6.39e-02 | 1.00e+00 | 3.924 | 1 | 2 | 38 |
GO:0050681 | androgen receptor binding | 6.39e-02 | 1.00e+00 | 3.924 | 1 | 3 | 38 |
GO:0000781 | chromosome, telomeric region | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 3 | 39 |
GO:0032729 | positive regulation of interferon-gamma production | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 2 | 39 |
GO:0007595 | lactation | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 2 | 39 |
GO:0043195 | terminal bouton | 6.88e-02 | 1.00e+00 | 3.815 | 1 | 1 | 41 |
GO:0042110 | T cell activation | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 3 | 42 |
GO:0030136 | clathrin-coated vesicle | 7.04e-02 | 1.00e+00 | 3.780 | 1 | 4 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 7.20e-02 | 1.00e+00 | 3.746 | 1 | 3 | 43 |
GO:0014070 | response to organic cyclic compound | 7.20e-02 | 1.00e+00 | 3.746 | 1 | 4 | 43 |
GO:0021762 | substantia nigra development | 7.36e-02 | 1.00e+00 | 3.713 | 1 | 2 | 44 |
GO:0015030 | Cajal body | 7.36e-02 | 1.00e+00 | 3.713 | 1 | 3 | 44 |
GO:0045727 | positive regulation of translation | 7.36e-02 | 1.00e+00 | 3.713 | 1 | 3 | 44 |
GO:0006281 | DNA repair | 7.45e-02 | 1.00e+00 | 2.144 | 2 | 18 | 261 |
GO:0043966 | histone H3 acetylation | 7.52e-02 | 1.00e+00 | 3.680 | 1 | 1 | 45 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 7.68e-02 | 1.00e+00 | 3.649 | 1 | 7 | 46 |
GO:0030216 | keratinocyte differentiation | 7.84e-02 | 1.00e+00 | 3.618 | 1 | 1 | 47 |
GO:0019827 | stem cell maintenance | 7.84e-02 | 1.00e+00 | 3.618 | 1 | 1 | 47 |
GO:0000902 | cell morphogenesis | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 2 | 49 |
GO:0030900 | forebrain development | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 2 | 49 |
GO:0022625 | cytosolic large ribosomal subunit | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 6 | 49 |
GO:0035690 | cellular response to drug | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 2 | 49 |
GO:0003684 | damaged DNA binding | 8.16e-02 | 1.00e+00 | 3.558 | 1 | 7 | 49 |
GO:0005743 | mitochondrial inner membrane | 8.26e-02 | 1.00e+00 | 2.058 | 2 | 8 | 277 |
GO:0019899 | enzyme binding | 8.26e-02 | 1.00e+00 | 2.058 | 2 | 12 | 277 |
GO:0006986 | response to unfolded protein | 8.32e-02 | 1.00e+00 | 3.528 | 1 | 2 | 50 |
GO:0031100 | organ regeneration | 8.32e-02 | 1.00e+00 | 3.528 | 1 | 4 | 50 |
GO:0005905 | coated pit | 8.32e-02 | 1.00e+00 | 3.528 | 1 | 3 | 50 |
GO:0006879 | cellular iron ion homeostasis | 8.48e-02 | 1.00e+00 | 3.500 | 1 | 4 | 51 |
GO:0004386 | helicase activity | 8.64e-02 | 1.00e+00 | 3.472 | 1 | 2 | 52 |
GO:0045216 | cell-cell junction organization | 8.96e-02 | 1.00e+00 | 3.417 | 1 | 2 | 54 |
GO:0002244 | hematopoietic progenitor cell differentiation | 8.96e-02 | 1.00e+00 | 3.417 | 1 | 1 | 54 |
GO:0000724 | double-strand break repair via homologous recombination | 9.12e-02 | 1.00e+00 | 3.391 | 1 | 3 | 55 |
GO:0001570 | vasculogenesis | 9.28e-02 | 1.00e+00 | 3.365 | 1 | 1 | 56 |
GO:0000723 | telomere maintenance | 9.28e-02 | 1.00e+00 | 3.365 | 1 | 6 | 56 |
GO:0012505 | endomembrane system | 9.28e-02 | 1.00e+00 | 3.365 | 1 | 2 | 56 |
GO:0051087 | chaperone binding | 9.75e-02 | 1.00e+00 | 3.290 | 1 | 6 | 59 |
GO:0042995 | cell projection | 9.90e-02 | 1.00e+00 | 3.265 | 1 | 6 | 60 |
GO:0006302 | double-strand break repair | 1.02e-01 | 1.00e+00 | 3.218 | 1 | 4 | 62 |
GO:0019903 | protein phosphatase binding | 1.02e-01 | 1.00e+00 | 3.218 | 1 | 4 | 62 |
GO:0030141 | secretory granule | 1.02e-01 | 1.00e+00 | 3.218 | 1 | 2 | 62 |
GO:0006338 | chromatin remodeling | 1.08e-01 | 1.00e+00 | 3.128 | 1 | 5 | 66 |
GO:0005813 | centrosome | 1.09e-01 | 1.00e+00 | 1.823 | 2 | 14 | 326 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 1.10e-01 | 1.00e+00 | 3.106 | 1 | 6 | 67 |
GO:0006289 | nucleotide-excision repair | 1.12e-01 | 1.00e+00 | 3.085 | 1 | 11 | 68 |
GO:0034329 | cell junction assembly | 1.12e-01 | 1.00e+00 | 3.085 | 1 | 1 | 68 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 1.15e-01 | 1.00e+00 | 3.043 | 1 | 2 | 70 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 1.21e-01 | 1.00e+00 | 2.963 | 1 | 6 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.22e-01 | 1.00e+00 | 2.943 | 1 | 2 | 75 |
GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process | 1.25e-01 | 1.00e+00 | 2.905 | 1 | 7 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 4 | 78 |
GO:0007565 | female pregnancy | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 1 | 78 |
GO:0002755 | MyD88-dependent toll-like receptor signaling pathway | 1.30e-01 | 1.00e+00 | 2.850 | 1 | 3 | 80 |
GO:0001726 | ruffle | 1.30e-01 | 1.00e+00 | 2.850 | 1 | 4 | 80 |
GO:0005681 | spliceosomal complex | 1.34e-01 | 1.00e+00 | 2.797 | 1 | 4 | 83 |
GO:0006898 | receptor-mediated endocytosis | 1.36e-01 | 1.00e+00 | 2.780 | 1 | 3 | 84 |
GO:0050821 | protein stabilization | 1.42e-01 | 1.00e+00 | 2.713 | 1 | 2 | 88 |
GO:0016605 | PML body | 1.42e-01 | 1.00e+00 | 2.713 | 1 | 3 | 88 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 1.45e-01 | 1.00e+00 | 2.680 | 1 | 7 | 90 |
GO:0006928 | cellular component movement | 1.46e-01 | 1.00e+00 | 2.664 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 1.46e-01 | 1.00e+00 | 2.664 | 1 | 8 | 91 |
GO:0071456 | cellular response to hypoxia | 1.48e-01 | 1.00e+00 | 2.649 | 1 | 6 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 1.48e-01 | 1.00e+00 | 2.649 | 1 | 5 | 92 |
GO:0051082 | unfolded protein binding | 1.49e-01 | 1.00e+00 | 2.633 | 1 | 5 | 93 |
GO:0006364 | rRNA processing | 1.51e-01 | 1.00e+00 | 2.618 | 1 | 6 | 94 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.60e-01 | 1.00e+00 | 1.482 | 2 | 15 | 413 |
GO:0014069 | postsynaptic density | 1.67e-01 | 1.00e+00 | 2.458 | 1 | 3 | 105 |
GO:0030308 | negative regulation of cell growth | 1.74e-01 | 1.00e+00 | 2.391 | 1 | 6 | 110 |
GO:0015630 | microtubule cytoskeleton | 1.74e-01 | 1.00e+00 | 2.391 | 1 | 4 | 110 |
GO:0072562 | blood microparticle | 1.76e-01 | 1.00e+00 | 2.378 | 1 | 3 | 111 |
GO:0006325 | chromatin organization | 1.86e-01 | 1.00e+00 | 2.290 | 1 | 5 | 118 |
GO:0007219 | Notch signaling pathway | 1.89e-01 | 1.00e+00 | 2.265 | 1 | 5 | 120 |
GO:0006260 | DNA replication | 1.90e-01 | 1.00e+00 | 2.253 | 1 | 9 | 121 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.97e-01 | 1.00e+00 | 2.195 | 1 | 5 | 126 |
GO:0031982 | vesicle | 2.04e-01 | 1.00e+00 | 2.139 | 1 | 9 | 131 |
GO:0042802 | identical protein binding | 2.04e-01 | 1.00e+00 | 1.253 | 2 | 20 | 484 |
GO:0007507 | heart development | 2.15e-01 | 1.00e+00 | 2.053 | 1 | 7 | 139 |
GO:0008286 | insulin receptor signaling pathway | 2.19e-01 | 1.00e+00 | 2.022 | 1 | 7 | 142 |
GO:0006457 | protein folding | 2.21e-01 | 1.00e+00 | 2.012 | 1 | 7 | 143 |
GO:0010628 | positive regulation of gene expression | 2.25e-01 | 1.00e+00 | 1.982 | 1 | 5 | 146 |
GO:0005615 | extracellular space | 2.29e-01 | 1.00e+00 | 0.855 | 3 | 17 | 957 |
GO:0005198 | structural molecule activity | 2.30e-01 | 1.00e+00 | 1.943 | 1 | 5 | 150 |
GO:0005769 | early endosome | 2.33e-01 | 1.00e+00 | 1.924 | 1 | 2 | 152 |
GO:0046777 | protein autophosphorylation | 2.41e-01 | 1.00e+00 | 1.868 | 1 | 7 | 158 |
GO:0000398 | mRNA splicing, via spliceosome | 2.49e-01 | 1.00e+00 | 1.815 | 1 | 8 | 164 |
GO:0030424 | axon | 2.51e-01 | 1.00e+00 | 1.797 | 1 | 4 | 166 |
GO:0006886 | intracellular protein transport | 2.58e-01 | 1.00e+00 | 1.754 | 1 | 5 | 171 |
GO:0004672 | protein kinase activity | 2.66e-01 | 1.00e+00 | 1.705 | 1 | 6 | 177 |
GO:0003714 | transcription corepressor activity | 2.67e-01 | 1.00e+00 | 1.696 | 1 | 8 | 178 |
GO:0032403 | protein complex binding | 2.73e-01 | 1.00e+00 | 1.657 | 1 | 10 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.75e-01 | 1.00e+00 | 1.649 | 1 | 8 | 184 |
GO:0003924 | GTPase activity | 2.91e-01 | 1.00e+00 | 1.550 | 1 | 12 | 197 |
GO:0005765 | lysosomal membrane | 2.99e-01 | 1.00e+00 | 1.507 | 1 | 5 | 203 |
GO:0006184 | GTP catabolic process | 3.12e-01 | 1.00e+00 | 1.431 | 1 | 12 | 214 |
GO:0005737 | cytoplasm | 3.19e-01 | 1.00e+00 | 0.293 | 8 | 110 | 3767 |
GO:0005759 | mitochondrial matrix | 3.29e-01 | 1.00e+00 | 1.339 | 1 | 14 | 228 |
GO:0008380 | RNA splicing | 3.29e-01 | 1.00e+00 | 1.339 | 1 | 11 | 228 |
GO:0008134 | transcription factor binding | 3.45e-01 | 1.00e+00 | 1.253 | 1 | 8 | 242 |
GO:0043025 | neuronal cell body | 3.49e-01 | 1.00e+00 | 1.236 | 1 | 9 | 245 |
GO:0004842 | ubiquitin-protein transferase activity | 3.60e-01 | 1.00e+00 | 1.178 | 1 | 6 | 255 |
GO:0000166 | nucleotide binding | 3.65e-01 | 1.00e+00 | 1.155 | 1 | 5 | 259 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 3.70e-01 | 1.00e+00 | 1.128 | 1 | 8 | 264 |
GO:0043065 | positive regulation of apoptotic process | 3.75e-01 | 1.00e+00 | 1.106 | 1 | 10 | 268 |
GO:0030198 | extracellular matrix organization | 3.91e-01 | 1.00e+00 | 1.028 | 1 | 4 | 283 |
GO:0005856 | cytoskeleton | 3.99e-01 | 1.00e+00 | 0.987 | 1 | 12 | 291 |
GO:0016567 | protein ubiquitination | 4.04e-01 | 1.00e+00 | 0.968 | 1 | 5 | 295 |
GO:0030154 | cell differentiation | 4.10e-01 | 1.00e+00 | 0.939 | 1 | 5 | 301 |
GO:0005525 | GTP binding | 4.19e-01 | 1.00e+00 | 0.896 | 1 | 12 | 310 |
GO:0043231 | intracellular membrane-bounded organelle | 4.28e-01 | 1.00e+00 | 0.859 | 1 | 9 | 318 |
GO:0007411 | axon guidance | 4.29e-01 | 1.00e+00 | 0.855 | 1 | 13 | 319 |
GO:0008283 | cell proliferation | 4.38e-01 | 1.00e+00 | 0.815 | 1 | 14 | 328 |
GO:0007155 | cell adhesion | 4.77e-01 | 1.00e+00 | 0.645 | 1 | 6 | 369 |
GO:0006508 | proteolysis | 4.85e-01 | 1.00e+00 | 0.610 | 1 | 9 | 378 |
GO:0046982 | protein heterodimerization activity | 4.87e-01 | 1.00e+00 | 0.602 | 1 | 13 | 380 |
GO:0009986 | cell surface | 5.07e-01 | 1.00e+00 | 0.521 | 1 | 11 | 402 |
GO:0006366 | transcription from RNA polymerase II promoter | 5.22e-01 | 1.00e+00 | 0.461 | 1 | 10 | 419 |
GO:0006355 | regulation of transcription, DNA-templated | 5.24e-01 | 1.00e+00 | 0.211 | 2 | 18 | 997 |
GO:0008270 | zinc ion binding | 5.24e-01 | 1.00e+00 | 0.211 | 2 | 12 | 997 |
GO:0005739 | mitochondrion | 5.24e-01 | 1.00e+00 | 0.209 | 2 | 28 | 998 |
GO:0055085 | transmembrane transport | 5.35e-01 | 1.00e+00 | 0.407 | 1 | 10 | 435 |
GO:0007596 | blood coagulation | 5.52e-01 | 1.00e+00 | 0.343 | 1 | 18 | 455 |
GO:0045893 | positive regulation of transcription, DNA-templated | 5.70e-01 | 1.00e+00 | 0.271 | 1 | 13 | 478 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 6.35e-01 | 1.00e+00 | 0.017 | 1 | 16 | 570 |
GO:0003677 | DNA binding | 6.36e-01 | 1.00e+00 | -0.078 | 2 | 28 | 1218 |
GO:0045087 | innate immune response | 6.52e-01 | 1.00e+00 | -0.047 | 1 | 24 | 596 |
GO:0005886 | plasma membrane | 6.79e-01 | 1.00e+00 | -0.162 | 4 | 45 | 2582 |
GO:0006351 | transcription, DNA-templated | 7.30e-01 | 1.00e+00 | -0.326 | 2 | 31 | 1446 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 7.55e-01 | 1.00e+00 | -0.452 | 1 | 19 | 789 |
GO:0016021 | integral component of membrane | 9.75e-01 | 1.00e+00 | -1.781 | 1 | 27 | 1982 |